author-photo

B Wang

Tianjin Medical University General Hospital

1

Papers

3

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

DOP01 Efficacy and safety of the IL-6 trans-signalling inhibitor olamkicept: a phase 2 randomized, placebo-controlled trial in moderately to severely active Ulcerative Colitis

2021 Journal of Crohn's and Colitis
Show All
- Source
- Cite
- Save
Citations (3)